- How Michael Jung’s team created a drug to extend the lives of men with prostate cancer
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.
March 15, 2018 10:00 AMdetail
- Multimodal approach improves survival in aggressive prostate cancer, study finds
UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the best chance of decreasing the mortality rate in men with aggressive prostate cancer. The findings also suggest that such a multimodal treatment approach has the best chance of preventing metastatic disease and improving overall long-term survival.
March 06, 2018 9:00 AMdetail
- Study shows need for early support among people with uveal melanoma
UCLA researchers found that nearly all people diagnosed with uveal melanoma had a number of unmet psychological and health information needs, particularly during the first three months after their diagnoses.
February 22, 2018 8:00 AMdetail
- STOP CANCER sunsets operation with $700,000 gift to UCLA Jonsson Comprehensive Cancer Center
UCLA will receive a $700,000 gift from STOP CANCER in support of the UCLA Jonsson Comprehensive Cancer Center and its researchers, providing critical funds to advance the university’s efforts in cancer research, education and treatment.
February 01, 2018 6:30 AMdetail
- Researchers link a relatively unknown gene to early emergence of blood diseases
UCLA researchers, in collaboration with the University of Iowa, discovered the contribution of a specific gene in the proper development of blood cells that give rise to hematopoietic stem cells. The findings identify a potential target for the development of treatments for some types of leukemia, anemia and other blood disorders.
January 31, 2018 9:00 AMdetail
- UCLA scientists use stem cells to study rare group of cancers that begin in germ cells
UCLA researchers have made new inroads into understanding germ cell tumors, a diverse and rare group of cancers that begin in germ cells — the cells that develop into sperm and eggs.
January 30, 2018 10:00 AMdetail
- With $3.1M grant from NIH, UCLA scientists to advance adoption of focal therapy to treat prostate cancer
UCLA researchers Dr. Leonard Marks and Shyam Natarajan will lead a $3.1 million research project grant awarded by the National Institutes of Health to advance the adoption of a promising new technology to treat men with prostate cancer.
January 26, 2018 10:00 AMdetail
- UCLA scientist receives prestigious grant to advance gastroenterology cancer research
Dr. Zev Wainberg, an associate professor of medicine at the David Geffen School of Medicine and co-director of the UCLA Gastrointestinal Oncology Program, has been awarded the 2018 Fishman Family Seed Grant in memory of Martin Fishman by STOP CANCER.
January 17, 2018 10:00 AMdetail
- Immunotherapy highly effective in treatment of rare skin cancer, study finds
In a UCLA-led study, more than two-thirds of people with a rare type of melanoma responded positively to treatment with anti-PD-1 immunotherapies.
January 10, 2018 6:00 AMdetail
- UCLA study finds link between breast cancer treatments and cellular markers of aging
A new study has found that women who had received chemotherapy and/or radiation to treat breast cancer were more likely to have high levels of DNA damage and reduced activity of an enzyme involved in chromosome healing, compared to women who underwent surgery alone.
December 12, 2017 11:00 AMdetail
- Researchers uncover cell changes behind therapy-resistant cancers, call for new clinical approaches
A UCLA study in collaboration with Caltech shows that skin cancer cells can be chemically changed from within to become resistant to targeted drugs.
December 11, 2017 2:00 PMdetail
- With $6.6 million award from PCORI, UCLA scientists to study effectiveness of strategies designed to increase the use of the HPV vaccine to prevent cancer
UCLA researcher Dr. Roshan Bastani will lead a $6.6 million research study awarded by the Patient-Centered Outcomes Research Institute (PCORI) to investigate the comparative effectiveness of strategies designed to increase receipt of the human papillomavirus (HPV) vaccine among adolescents.
November 30, 2017 8:00 AMdetail
- Maie's Margin
As a head and neck cancer surgeon, Dr. Maie St. John is no stranger to making tough decisions. During each operation, Dr. St. John is tasked with a difficult and conflicting role, to resect the tumor in its entirety while also preserving as much of the surrounding healthy tissue as possible.
November 27, 2017 9:00 AMdetail
- UCLA scientists design nanotechnology platform for cancer immunotherapy, inducing immunogenic cell death in pancreatic cancer
UCLA researchers have developed a novel nanotechnology platform, which uses nanoparticles to deliver a selected cancer drug to the pancreatic cancer tumor environment where it induces a special form of tumor cell death known as immunogenic cell death or ICD.
November 27, 2017 6:00 AMdetail
- UCLA researcher to receive ASCO’s Ellen L. Stovall Award and Lecture for advancement of cancer survivorship care
In two papers published in the Journal of the National Cancer Institute researchers from UCLA, UC Davis and other institutions have found that peripheral neuropathy, which causes pain, numbness, and tingling in hands and/or feet, can bother early-stage breast cancer patients years after completing chemotherapy.
November 22, 2017 9:00 AMdetail
- UCLA scientists help author major report to accelerate cancer research and care, delivering on US Cancer Moonshot initiative
A fundamental shift in how cancer research is conducted and cancer care is provided in the United States is required in order to deliver on the US Cancer Moonshot initiative, according to a major new report published today in The Lancet Oncology.
November 01, 2017 9:30 AMdetail
- Renowned UCLA physician-scientist awarded collaborative grant to develop innovative technologies to detect and prevent lung cancer
UCLA cancer researcher Dr. Steven Dubinett will co-lead a $5 million collaborative grant from Stand Up to Cancer to develop new tools to diagnose lung cancer and protect against recurrence in people successfully treated for the disease.
October 26, 2017 2:30 PMdetail
- UCLA scientist honored for outstanding contributions to advancing the understanding of the molecular mechanisms of cancer
Dr. Guillaume Chanfreau, a professor of chemistry and biochemistry at the David Geffen School of Medicine, will receive the American Cancer Society’s Giants of Science Determination Award for his outstanding contributions to the study of the molecular mechanisms that drive cancer.
October 13, 2017 9:45 AMdetail
- With $3M grant from Stand Up to Cancer, UCLA researcher to advance understanding of how a promising new combination therapy could overcome melanoma resistance to immunotherapy
Dr. Antoni Ribas, director of the UCLA Jonsson Comprehensive Cancer Center’s Tumor Immunology Program and a professor of medicine at the David Geffen School of Medicine, has received a $3 million grant from Stand Up to Cancer to study the factors that shape how metastatic melanoma responds to a promising new drug combination therapy.
October 13, 2017 9:45 AMdetail
- Make cancer less scary
This Halloween, researchers at the UCLA Jonsson Comprehensive Cancer Center share what scares them the most and remind us how important philanthropy is to fueling the research and support services so vital to cancer patients and their families.
October 13, 2017 9:00 AMdetail